Introduction and vote

Date 01 October 2012
Event ESMO Congress 2012
Session Can neo-adjuvant breast cancer data be used to accelerate drug approval?
Topics Anti-Cancer Agents & Biologic Therapy
Breast Cancer
Presenter Hans-Joerg Senn
Authors H. Senn
  • Tumor-und Brustzentrum ZeTuP AG, CH-9006 - St. Gallen/CH